132 related articles for article (PubMed ID: 6827310)
21. The immunopathology of myasthenia gravis.
Lennon VA
Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
[TBL] [Abstract][Full Text] [Related]
22. Antigenic modulation of human myotube acetylcholine receptor by myasthenic sera. Serum titer determines receptor internalization rate.
Tzartos SJ; Sophianos D; Zimmerman K; Starzinski-Powitz A
J Immunol; 1986 May; 136(9):3231-8. PubMed ID: 3958494
[TBL] [Abstract][Full Text] [Related]
23. Immunology of the acetylcholine receptor.
Lennon VA
Immunol Commun; 1976; 5(4):323-44. PubMed ID: 61167
[TBL] [Abstract][Full Text] [Related]
24. Conjugation of acetylcholine receptor-protecting Fab fragments with polyethylene glycol results in a prolonged half-life in the circulation and reduced immunogenicity.
Trakas N; Tzartos SJ
J Neuroimmunol; 2001 Nov; 120(1-2):42-9. PubMed ID: 11694318
[TBL] [Abstract][Full Text] [Related]
25. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
[TBL] [Abstract][Full Text] [Related]
26. New antigen for antibody detection in myasthenia gravis.
Gotti C; Mantegazza R; Clementi F
Neurology; 1984 Mar; 34(3):374-7. PubMed ID: 6538281
[TBL] [Abstract][Full Text] [Related]
27. Intrathymic pathogenesis of myasthenia gravis: transient expression of acetylcholine receptors on thymus-derived myogenic cells.
Wekerle H; Ketelsen UP; Zurn AD; Fulpius BW
Eur J Immunol; 1978 Aug; 8(8):579-82. PubMed ID: 699955
[TBL] [Abstract][Full Text] [Related]
28. Interaction of myasthenic serum globulin with the acetylcholine receptor.
Almon RR; Appel SH
Biochim Biophys Acta; 1975 May; 393(1):66-77. PubMed ID: 1138925
[TBL] [Abstract][Full Text] [Related]
29. Electrophysiological effects of myasthenic serum factors studied in mouse muscle.
Lerrick AJ; Wray D; Vincent A; Newsom-Davis J
Ann Neurol; 1983 Feb; 13(2):186-91. PubMed ID: 6830177
[TBL] [Abstract][Full Text] [Related]
30. Myasthenia gravis and myasthenic syndromes.
Engel AG
Ann Neurol; 1984 Nov; 16(5):519-34. PubMed ID: 6095730
[TBL] [Abstract][Full Text] [Related]
31. Myasthenic globulin enhances the loss of acetylcholine receptor clusters.
Bursztajn S; McManaman JL; Elias SB; Appel SH
Science; 1983 Jan; 219(4581):195-7. PubMed ID: 6849132
[TBL] [Abstract][Full Text] [Related]
32. Acetylcholine receptor antibody characteristics in myasthenia gravis. Fractionation of alpha-bungarotoxin binding site antibodies and their relationship to IgG subclass.
Whiting PJ; Vincent A; Newsom-Davis J
J Neuroimmunol; 1983 Aug; 5(1):1-9. PubMed ID: 6874919
[TBL] [Abstract][Full Text] [Related]
33. Components of Torpedo electric organ and muscle that cause aggregation of acetylcholine receptors on cultured muscle cells.
Godfrey EW; Nitkin RM; Wallace BG; Rubin LL; McMahan UJ
J Cell Biol; 1984 Aug; 99(2):615-27. PubMed ID: 6746740
[TBL] [Abstract][Full Text] [Related]
34. Antibodies in sera from patients with myasthenia gravis do not bind to nicotinic acetylcholine receptors from human brain.
Whiting PJ; Cooper J; Lindstrom JM
J Neuroimmunol; 1987 Oct; 16(2):205-13. PubMed ID: 3624454
[TBL] [Abstract][Full Text] [Related]
35. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
[TBL] [Abstract][Full Text] [Related]
36. Effect of myasthenic patient sera on the number and distribution of acetylcholine receptors in muscle and nerve-muscle cultures from rat. Correlations with clinical state.
Eymard B; de la Porte S; Pannier C; Berrih-Aknin S; Morel E; Fardeau M; Bach JF; Koenig J
J Neurol Sci; 1988 Aug; 86(1):41-59. PubMed ID: 3171596
[TBL] [Abstract][Full Text] [Related]
37. Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor.
Barchan D; Asher O; Tzartos SJ; Fuchs S; Souroujon MC
Eur J Immunol; 1998 Feb; 28(2):616-24. PubMed ID: 9521072
[TBL] [Abstract][Full Text] [Related]
38. Antibodies to the nicotinic acetylcholine receptor, obtained from serum of myasthenic patients, may decrease acetylcholine release from rat hippocampal nerve endings in vitro.
Heilbronn E; Häggblad J; Kubát B
Ann N Y Acad Sci; 1981; 377():198-207. PubMed ID: 6951473
[TBL] [Abstract][Full Text] [Related]
39. Patient-specific anti=acetylcholine receptor antibody patterns in myasthenia gravis.
Savage-Marengo T; Harrison R; Lunt GG; Behan PO
J Neurol Neurosurg Psychiatry; 1980 Apr; 43(4):316-20. PubMed ID: 7373331
[TBL] [Abstract][Full Text] [Related]
40. The pathophysiology of penicillamine-induced myasthenia gravis.
Kuncl RW; Pestronk A; Drachman DB; Rechthand E
Ann Neurol; 1986 Dec; 20(6):740-4. PubMed ID: 3813503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
